Patient Controlled Injectors Market

Patient Controlled Injectors Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

143

Base Year:

2022

Sep - 2023

Format:

Report Code:

VMR-2291

Segments Covered

By Product Electronic Wearable Injector, Mechanical Wearable Injector, Infusion Pumps
By Application Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment, Other Applications
By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 2.5 Billion
Revenue 2030:	USD 5.8 Billion
Revenue CAGR (2023 - 2030):	12.8%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Patient Controlled Injectors Market - Segment Analysis
1. Overview
2. Global Patient Controlled Injectors Market, 2016 - 2028 (USD Million)
3. Global Patient Controlled Injectors Market - by Product
  1. By Electronic Wearable Injector
  2. By Mechanical Wearable Injector
  3. By Infusion Pumps
4. Global Patient Controlled Injectors Market - by Application
  1. By Cancer Treatment
  2. By Auto-immune Treatment
  3. By Blood Disorders Treatment
  4. By Other Applications
5. Global Patient Controlled Injectors Market - by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Mail Order Pharmacies
6. Global Patient Controlled Injectors Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
7. Market comparative analysis
North America Patient Controlled Injectors Market - Segment Analysis
1. Overview
2. North America Patient Controlled Injectors Market, 2016 - 2028 (USD Million)
3. North America Patient Controlled Injectors Market, by Product
  1. By Electronic Wearable Injector
  2. By Mechanical Wearable Injector
  3. By Infusion Pumps
4. North America Patient Controlled Injectors Market, by Application
  1. By Cancer Treatment
  2. By Auto-immune Treatment
  3. By Blood Disorders Treatment
  4. By Other Applications
5. North America Patient Controlled Injectors Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Mail Order Pharmacies
6. North America Patient Controlled Injectors Market, by Country
  1. U.S.
    1. U.S. Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. U.S. Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. U.S. Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  2. Canada
    1. Canada Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. Canada Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. Canada Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  3. Mexico
    1. Mexico Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. Mexico Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. Mexico Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
Europe Patient Controlled Injectors Market - Segment Analysis
1. Overview
2. Europe Patient Controlled Injectors Market, 2016 - 2028 (USD Million)
3. Europe Patient Controlled Injectors Market, by Product
  1. By Electronic Wearable Injector
  2. By Mechanical Wearable Injector
  3. By Infusion Pumps
4. Europe Patient Controlled Injectors Market, by Application
  1. By Cancer Treatment
  2. By Auto-immune Treatment
  3. By Blood Disorders Treatment
  4. By Other Applications
5. Europe Patient Controlled Injectors Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Mail Order Pharmacies
6. Europe Patient Controlled Injectors Market, by Country
  1. Germany
    1. Germany Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. Germany Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. Germany Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  2. UK
    1. UK Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. UK Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. UK Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  3. France
    1. France Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. France Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. France Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  4. Spain
    1. Spain Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. Spain Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. Spain Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  5. Italy
    1. Italy Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. Italy Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. Italy Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  6. BENELUX
    1. BENELUX Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. BENELUX Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. BENELUX Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  7. Rest of Europe
    1. Rest Of Europe Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. Rest Of Europe Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. Rest Of Europe Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
Asia Pacific Patient Controlled Injectors Market - Segment Analysis
1. Overview
2. Asia Pacific Patient Controlled Injectors Market, 2016 - 2028 (USD Million)
3. Asia Pacific Patient Controlled Injectors Market, by Product
  1. By Electronic Wearable Injector
  2. By Mechanical Wearable Injector
  3. By Infusion Pumps
4. Asia Pacific Patient Controlled Injectors Market, by Application
  1. By Cancer Treatment
  2. By Auto-immune Treatment
  3. By Blood Disorders Treatment
  4. By Other Applications
5. Asia Pacific Patient Controlled Injectors Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Mail Order Pharmacies
6. Asia Pacific Patient Controlled Injectors Market, by Country
  1. China
    1. China Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. China Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. China Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  2. Japan
    1. Japan Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. Japan Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. Japan Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  3. India
    1. India Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. India Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. India Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  4. South Korea
    1. South Korea Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. South Korea Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. South Korea Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  5. South East Asia
    1. South East Asia Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. South East Asia Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. South East Asia Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. Rest of Asia Pacific Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. Rest of Asia Pacific Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
Latin America Patient Controlled Injectors Market - Segment Analysis
1. Overview
2. Latin America Patient Controlled Injectors Market, 2016 - 2028 (USD Million)
3. Latin America Patient Controlled Injectors Market, by Product
  1. By Electronic Wearable Injector
  2. By Mechanical Wearable Injector
  3. By Infusion Pumps
4. Latin America Patient Controlled Injectors Market, by Application
  1. By Cancer Treatment
  2. By Auto-immune Treatment
  3. By Blood Disorders Treatment
  4. By Other Applications
5. Latin America Patient Controlled Injectors Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Mail Order Pharmacies
6. Latin America Patient Controlled Injectors Market, by Country
  1. Brazil
    1. Brazil Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. Brazil Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. Brazil Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  2. Argentina
    1. Argentina Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. Argentina Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. Argentina Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  3. Rest of Latin America
    1. Rest of Latin America Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. Rest of Latin America Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. Rest of Latin America Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
Middle East & Africa Patient Controlled Injectors Market - Segment Analysis
1. Overview
2. Middle East & Africa Patient Controlled Injectors Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Patient Controlled Injectors Market, by Product
  1. By Electronic Wearable Injector
  2. By Mechanical Wearable Injector
  3. By Infusion Pumps
4. Middle East & Africa Patient Controlled Injectors Market, by Application
  1. By Cancer Treatment
  2. By Auto-immune Treatment
  3. By Blood Disorders Treatment
  4. By Other Applications
5. Middle East & Africa Patient Controlled Injectors Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Mail Order Pharmacies
6. Middle East & Africa Patient Controlled Injectors Market, by Country
  1. GCC Countries
    1. GCC Countries Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. GCC Countries Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. GCC Countries Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  2. South Africa
    1. South Africa Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. South Africa Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. South Africa Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Patient Controlled Injectors Market, By Product
      1. By Electronic Wearable Injector
      2. By Mechanical Wearable Injector
      3. By Infusion Pumps
    2. Rest of Middle East & Africa Patient Controlled Injectors Market, By Application
      1. By Cancer Treatment
      2. By Auto-immune Treatment
      3. By Blood Disorders Treatment
      4. By Other Applications
    3. Rest of Middle East & Africa Patient Controlled Injectors Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Mail Order Pharmacies
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. West Pharmaceutical Services Inc. (U.S.)
2. Gerresheimer AG (Germany)
3. F. Hoffmann-La Roche Ltd. (Switzerland)
4. Johnson and Johnson Services Inc. (U.S.)
5. Ypsomed AG (Switzerland)
6. Westbourne Medical Limited (UK)
7. Enable Injections (U.S.)
8. SCPharmaceuticals Inc. (U.S.)
9. United Therapeutics Corporation (U.S.)
10. Becton Dickinson and Company (U.S.)
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 21-Sep-2023

Patient Controlled Injectors Market to Reach Valuation of USD 5.8 Billion by 2030 – the Increasing Prevalence of Chronic Diseases and the Growing Need for Self-Administration of Medications Drives the Market

FAQ

Frequently Asked Question

What is the global demand for Patient Controlled Injectors in terms of revenue?

The global Patient Controlled Injectors valued at USD 2.5 Billion in 2022 and is expected to reach USD 5.8 Billion in 2030 growing at a CAGR of 12.8%.

Which are the prominent players in the market?

The prominent players in the market are West Pharmaceutical Services Inc. (U.S.), Gerresheimer AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Johnson and Johnson Services Inc. (U.S.), Ypsomed AG (Switzerland), Westbourne Medical Limited (UK), Enable Injections (U.S.), SCPharmaceuticals Inc. (U.S.), United Therapeutics Corporation (U.S.), Becton Dickinson and Company (U.S.).

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 12.8% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Patient Controlled Injectors include
- Increasing Prevalence of Chronic Diseases

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Patient Controlled Injectors in 2022.

Patient Controlled Injectors Market

Patient Controlled Injectors Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Patient Controlled Injectors in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Vantage Market Research

Products & Services

Media

Contact Us

Patient Controlled Injectors Market

Patient Controlled Injectors Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Patient Controlled Injectors in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Patient Controlled Injectors Market

Vantage Point Interactive Dashboard